This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arif M, Sadayappan S, Becker RC, Martin LJ, Urbina EM. Epigenetic modification: a regulatory mechanism in essential hypertension. Hypertens Res. 2019;42:1099–113.
Salem H, Hasan DM, Eameash A, El-Mageed HA, Hasan S, Ali R. Worldwide prevalence of hypertension: a pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. J Am Coll Cardiol. 2018;71:1 [Supplement].
Jeppesen DK, Fenix AM, Franklin JL, Higginbotham JN, Zhang Q, Zimmerman LJ, et al. Reassessment of Exosome Composition. Cell 2019;177:428–.e18.
Komal S, Yin JJ, Wang SH, Huang CZ, Tao HL, Dong JZ, et al. MicroRNAs: emerging biomarkers for atrial fibrillation. J Cardiol. 2019; S0914-5087:30204–7.
Ye Y, Yang J, Lv W, Lu Y, Zhang L, Zhang Y, et al. Screening of differentially expressed microRNAs of essential hypertension in Uyghur population. Lipids Health Dis. 2019;18:98.
Keerthikumar S, Chisanga D, Ariyaratne D, Al Saffar H, Anand S, Zhao K, et al. ExoCarta: a web-based compendium of exosomal cargo. J Mol Biol. 2016;428:688–92.
Zhao X, Yi Y, Meng C, Fang N. MiRNA-575 suppresses angiogenesis by targeting Rab5-MEK-ERK pathway in endothelial cells. Biosci Rep. 2019;39:BSR20181218.
Assalin HB, Gontijo JAR, Boer PA. miRNAs, target genes expression and morphological analysis on the heart in gestational protein-restricted offspring. PLoS ONE. 2019;14:e0210454.
Qi H, Liu Z, Liu B, Cao H, Sun W, Yan Y, et al. micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension. Med (Baltim). 2017;96:e6417.
Solayman MH, Langaee T, Patel A, El-Wakeel L, El-Hamamsy M, Badary O, et al. Identification of suitable endogenous normalizers for qRT-PCR analysis of plasma microRNA expression in essential hypertension. Mol Biotechnol. 2016;58:179–87.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jayaseelan, V.P., Arumugam, P. Exosomal microRNAs as a promising theragnostic tool for essential hypertension. Hypertens Res 43, 74–75 (2020). https://doi.org/10.1038/s41440-019-0343-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41440-019-0343-2